War on Cancer Asia- Pacific 2017 meet set for Singapore
BY: Annette Kora
More than 150 senior health care leaders from Asia- Pacific will be attending the Economist Events’ War on Cancer 2017 that will take place on the 30th of March in Singapore.
Representatives from WHO and the civil society, Ministries of health, industry experts and many others will be present to participate in the discussions.
The event will present new thinking on scaling up the response to cancer in low- and middle-income countries and innovative ways to finance cancer control in Asia.
The Chief Executive Officer of the Union for International Cancer Control (UICC), Cary Adams, will address the challenges facing cities as the engine to accelerate cancer control and present the new city-level initiative.
Interested individuals and organizations who want to find out more information about the programme and speakers can visit the following website stated below.
By: The Economist
Having sufficient financing that is spent efficiently is central to successful cancer strategies. The intersection of economics, finance and public policy is where The Economist Events believes it can add real value in the cancer discussion in Asia. The War on Cancer 2017 will focus on this premise by bringing together regional cancer and healthcare stakeholders for a wide-ranging and robust discussion with the broader world of finance—with finance ministry officials, global and regional experts in financing healthcare, and private-sector financing and investment, including philanthropic and impact investors.
Barely a fraction of global spending on cancer is undertaken in low- and middle-income countries. Asia is no exception. Despite these countries having the highest number of deaths from cancer, and with large out-of-pocket payments often causing catastrophic economic consequences for individuals and families, building and sustaining complex, multi-dimensional cancer care systems is challenging to plan and execute, as well as expensive to finance. Most countries in developing Asia struggle with the growing cancer burden; quite a few are unable to keep pace.
There are bright spots. A new age of universal healthcare in the region, along with ageing populations, is prompting discussion of how cancer fits in. Countries like Thailand are leading the way in cost-effectiveness analysis and decisions based on evidence and outcomes. Recent reports on cancer surgery and radiotherapy suggest new ways of building the clinical response to cancers, and prioritizing high-impact, cost-effective interventions for addressable cancers.
There are no simple solutions, but plenty of best practices to draw on; new thinking around how to scale up the response to cancer; and opportunities to re-think how governments, the international community and the private sector can accelerate the funding of improved cancer control. That is our aim in 2017, to explore in greater depth how best to build affordable cancer care in low- and middle-income countries in Asia, to ask which cancer interventions make best sense, and how best they can be financed.